Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Yaokai Chen and Vijay Harypursat.
Yaokai Chen
Connection Strength
1.769
Vijay Harypursat
  1. Six weeks into the 2019 coronavirus disease outbreak: it is time to consider strategies to impede the emergence of new zoonotic infections. Chin Med J (Engl). 2020 May 05; 133(9):1118-1120.
    View in: PubMed
    Score: 0.880
  2. Predictive factors of progression to severe COVID-19. Open Med (Wars). 2020; 15(1):805-814.
    View in: PubMed
    Score: 0.225
  3. No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study. Front Pharmacol. 2020; 11:1071.
    View in: PubMed
    Score: 0.223
  4. Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol. Chin Med J (Engl). 2020 May 05; 133(9):1132-1134.
    View in: PubMed
    Score: 0.220
  5. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial. Chin Med J (Engl). 2020 May 05; 133(9):1080-1086.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.